Skip to main content
SpringerLink
Log in

Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen

  • Living reference work entry
  • First Online:
Kinderchirurgie

Part of the book series: Springer Reference Medizin ((SRM))

  • 663 Accesses

Zusammenfassung

Chronisch-entzündliche Darmerkrankungen (CED; Morbus Crohn, Colitis ulcerosa, CED-unklassifiziert [inflammatory bowel disease-unclassified; IBD-U]) werden bei 20–25 % der Patienten bereits im Kindes- und Jugendalter manifest. Die Entzündung verläuft in chronisch-rezidivierenden Schüben, eine Ursache ist bis heute nicht bekannt. Bereits 1932 von Burrill B. Crohn als „Ileitis terminalis“ erstmals beschrieben, wurde rasch erkennbar, dass auch der Morbus Crohn nicht nur auf das terminale Ileum beschränkt bleibt. Daher muss mit moderner Diagnostik der gesamte Gastrointestinaltrakt dargestellt werden, um eine individuelle Therapie zu planen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Abdullah BA, Gupta SK, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR, Fitzgerald JF (2002) The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr 35:636–640

    Article  Google Scholar 

  • Alexopoulou E, Xenophontos PE, Economopoulos N, Spyridopoulos TN, Papakonstantinou O, Panayotou I, Dimakou K, Roma E, Kelekis NL (2012) Investigative magnetic resonance cholangiopancreatography fpr Primary Sclerosing Cholangitis (PSC)-type lesions in children with Inflammatory Bowel Disease (IBD): results from a cross-sectional study. J Pediatr Gastroenterol Nutr 55(3):308–313

    Article  Google Scholar 

  • Arguelles-Arias F, Donat E, Fernandez-Uerien I, Albeca F, Arguelles-Martin F, Martinez MJ, Molina M, Varea V, Herrerias-Gutierrez JM, Ribes-Koninckx C (2015) Guideline for wireless capsule endoscopy in children and adolescents: a consensus document by the SEGHNP (Spanish society for pediatric gastroenterology, hepatology and nutrition) and the SEPD (Spanish society for digestive diseases). Rev Esp Enferm Dig 107:714–731

    PubMed  Google Scholar 

  • Baldassano RN, Han PD, Jeshion WC, Berlin JA, Piccoli DA, Lautenbach E, Mick R, Lichtenstein GR (2001) Pediatric Crohn’s disease: risk factors for postoperative recurrence. Am J Gastroenterol 96:2169–2176

    Article  CAS  Google Scholar 

  • Becker JM (1999) Surgical therapy for ulcerative colitis and Crohn’s disease. Gastroenterol Clin North Am 28:371–390

    Article  CAS  Google Scholar 

  • Benchimol EI, Fortinsky KJ, Gozdyra P, van den Heuvel M, van Limbergen J, Griffiths AM (2011) Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 17:423–439

    Article  Google Scholar 

  • Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101:1559–1568

    Article  Google Scholar 

  • Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S (2006) Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 4:744–753

    Article  Google Scholar 

  • Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM (2000) Oral tacrolimus treatment of severe colitis in children. J. Pediatr 137:794–799

    Article  CAS  Google Scholar 

  • Boyle B, Mackner L, Ross C, Moses J, Kumar S, Crandall W (2010) A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 51:714–717

    Article  CAS  Google Scholar 

  • Buderus S, Scholz D, Behrens R, Classen M, de Laffolie J, Keller KM, Zimmer KP, Koletzko S (2015) Inflammatory bowel disease in pediatric patients – characteristics of newly diagnosed patients from the CEDATA-GPGE registry. Dtsch Arztebl Int 112:121–127

    PubMed  PubMed Central  Google Scholar 

  • Bunn SK, Bisset WM, Main MJ, Golden BE (2001) Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 32:171–177

    Article  CAS  Google Scholar 

  • Cameron FL, Gerasimidis K, Papangelou A, Missiou D, Garrick V, Cardigan T, Buchanan E, Barclay AR, McGrogan P, Russell RK (2013) Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn’s disease. Aliment Pharmacol Ther 37:622–629

    Article  CAS  Google Scholar 

  • Canani RB, de Horatio LT, Terrin G, Romano MT, Miele E, Staiano A, Rapacciuolo L, Polito G, Bisesti V, Manguso F, Vallone G, Sodano A, Troncone R (2006) Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr 42:9–15

    Article  Google Scholar 

  • Casson DH, Eltumi M, Tomlin S, Walker-Smith JA, Murch SH (2000) Topical tacrolimus may be effective in the treatment of oral and perineal Crohn’s disease. Gut 47:436–440

    Article  CAS  Google Scholar 

  • Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ (2004) The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients. Gastroenterology 126:19–31

    Article  CAS  Google Scholar 

  • Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, JE L-J (1994) Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343:1249–1252

    Article  CAS  Google Scholar 

  • Critch J, Day AS, Otley A, King-Moore C, Teitelbaum JE, Shashidhar H, NASPGHAN IBD Committee (2012) Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 54:298–305

    Article  Google Scholar 

  • Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL (2008) Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr 47:61–67

    Article  CAS  Google Scholar 

  • Diamond IR, Langer JC (2001) Laparoscopic-assisted versus open ileocolic resection for adolescent Crohn disease. J Pediatr Gastroenterol Nutr 33:543–547

    Article  CAS  Google Scholar 

  • Dolgin SE (2007) Surgical management of upper gastrointestinal and small bowel Crohn’s disease. Semin Pediatr Surg 16:172–177

    Article  Google Scholar 

  • Egan LJ, Sandborn WJ, Tremaine WJ (1998) Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn’s disease with intravenous cyclosporine. Am J Gastroenterol 93:442–448

    Article  CAS  Google Scholar 

  • Eidelwein AP, Thompson R, Fiorino K, Abadom V, Oliva-Hemker M (2007) Disease presentation and clinical course in black and white children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44:555–560

    Article  Google Scholar 

  • Ekbom A, Helmick C, Zack M, Adami HO (1990) Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 336:357–359

    Article  CAS  Google Scholar 

  • Eliakim R, Fischer D, Suissa A, Yassin K, Katz D, Guttman N, Migdal M (2003) Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn’s disease. Eur J Gastroenterol Hepatol 15:363–367

    Article  Google Scholar 

  • Faubion WA, Dubinsky M, Ruemmele FM, Escher J, Rosh J, Hyams JS, Eichner S, Li Y, Reilly N, Thakkar RB, Robinson AM, Lazar A (2017) Long-term efficacy and safety of adalimumab in pediatric patients with Crohn’s disease. Inflamm Bowel Dis 23:453–460

    Article  Google Scholar 

  • Feldstein AE, Perrault J, El Youssif M, Lindor KD, Freese DK, Angulo P (2003) Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 38:210–217

    Article  Google Scholar 

  • Fellermann K, Steffen M, Stein J, Raedler A, Hämling J, Ludwig D, Loeschke K, Stange EF (2000) Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther 14:171–176

    Article  CAS  Google Scholar 

  • Ferlitsch A, Teml A, Reinisch W, Ulbrich G, Wrba F, Homoncik M, Gangl A, Peck-Radosavljevic M, Vogelsang H (2007) 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension. Am J Gastroenterol 102:2495–2503

    Article  CAS  Google Scholar 

  • Franke A, McGovern DP, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42:1118–1125

    Article  CAS  Google Scholar 

  • Friedlander JA, Liu QY, Sahn KK, Walsh CM, Kramer RE, Lightdale JR, Khlevner J, McOmber M, Kurowski J, Giefer MJ, Pall H, Troendle DM, Utterson EC, Brill H, Zacur GM, Lirio RA, Lerner DG, Reynolds C, Gibbons TE, Wilsey M, Liacouras CA, Fishman DS (2017) NASPGHAN capsule endoscopy clinical report. J Pediatr Gastroenterol Nutr 64:485–494

    Article  Google Scholar 

  • Gale HI, Sharatz SM, Taphey M, Bradley WF, Nimkin K, Gee MS (2017) Comparison of CT-enterography and MR-enterography imaging features of active crohn’s disease in children and adolescents. Pediastr Radiol 47:1321–1328

    Article  Google Scholar 

  • Gregorio GV, Portmann B, Karani J et al (2001) Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33:544–553

    Article  CAS  Google Scholar 

  • Griffiths AM (2004) Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 18:509–523

    Article  Google Scholar 

  • Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 108:1056–1067

    Article  CAS  Google Scholar 

  • Hanauer SB, Present DH (2003) The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 3:81–92

    PubMed  Google Scholar 

  • Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine rich repeat variantswith susceptibility to Crohn’s disease. Nature 411:599–603

    Article  CAS  Google Scholar 

  • Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R (2007) Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children. Gastroenterology 132:863–873

    Article  CAS  Google Scholar 

  • Hyams J, Walters TD, Crandall W, Kugathasan S, Griffiths A, Blank M, Johanns J, Lang Y, Markowitz J, Cohen S, Winter HS, Veereman-Wauters G, Ferry G, Baldassano R (2011) Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension. Curr Med Res Opin 27:651–652

    Article  CAS  Google Scholar 

  • Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA, Colletti RB, Dubinsky M, Kierkus J, Rosh J, Wang Y, Huang B, Bittle B, Marshall M, Lazar A (2012) Safety and efficacy of adalimumab for moderate to severe Crohn’s disease in children. Gastroenterology 143:365–374

    Article  CAS  Google Scholar 

  • Jose FA, Heyman MB (2008) Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 46:124–133

    Article  Google Scholar 

  • Koivusalo A, Pakarinen MP, Rintala RJ (2007) Surgical complications in relation to functional outcomes after ileoanal anastomosis in pediatric patients with ulcerative colitis. J Pediatr Surg 42:290–295

    Article  Google Scholar 

  • Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, Leleiko N, Mack D, Griffiths A, Bousvaros A, Evans J, Mezoff A, Moyer S, Oliva-Hemker M, Otley A, Pfefferkorn M, Crandall W, Wyllie R, Hyams J (2007) Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 151:523–527

    Article  Google Scholar 

  • Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PMA, Imielinski M, Guthery SL, Cucchiara S, Kim CE, Frackelton EC, Annaiah K, Glessner JT, Santa E, Willson T, Eckert AW, Bonkowski E, Shaner JL, Smith RM, Otieno FG, Peterson N, Abrams DJ, Chiavacci RM, Grundmeier R, Mamula P, Tomer G, Piccoli DA, Monos DS, Annese V, Denson LA, Grant SFA, Hakonarson H (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40:1211–1215

    Article  CAS  Google Scholar 

  • Lehtinen P, Ashorn M, Iltanen S, Jauhola R, Jauhonen P, Kolho KL, Auvinen A (2011) Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis 17:1778–1783

    Article  Google Scholar 

  • Lindor KD (2011) New treatment strategies for primary sclerosing cholangitis. Dig Dis 29:113–116

    Article  Google Scholar 

  • Loftus EV Jr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ (2005) PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54:91–96

    Article  Google Scholar 

  • Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ III, Sandborn WJ (2007) Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis 13:254–261

    Article  Google Scholar 

  • Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA (1998) Methotrexate in patients with Crohn’s disease after 6-mercaptopurine. J Pediatr 132:830–835

    Article  CAS  Google Scholar 

  • Mack DR, Langton C, Markowitz J, Leleiko N, Griffiths A, Bousvaros A, Evans J, Kugathasan S, Otley A, Pfefferkorn M, Rosh J, Mezoff A, Moyer S, Oliva-Hemker M, Rothbaum R, Wyllie R, delRosario JF, Keljo D, Lerer T, Hyams J (2007) Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 119:1113–1119

    Article  Google Scholar 

  • Meier AH, Roth L, Cilley RE, Dillon PW (2007) Completely minimally invasive approach to restorative total proctocolectomy with j-pouch construction in children. Surg Laparosc Endosc Percutan Tech 17:418–421

    Article  Google Scholar 

  • Neurath MF, Wanitschke R, Peters M, Krummenauer F, Meyer zum Buschenfelde KH, Schlaak JF (1999) Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease. Gut 44:625–628

    Article  CAS  Google Scholar 

  • OOrd T, Hornung N (2014) Fecal calprotectin in healthy children. Scan J Clin Lab Invest 74:254–258

    Article  CAS  Google Scholar 

  • Peppercorn MA (1997) Antibiotics are effective therapy for Crohn’s disease. Inflamm Bowel Dis 3:318–319

    Article  CAS  Google Scholar 

  • Proctor ML, Langer JC, Gerstle JT, Kim PC (2002) Is laparoscopic subtotal colectomy better than open subtotal colectomy in children? J Pediatr Surg 37:706–708

    Article  CAS  Google Scholar 

  • Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, Otley A, Rosh J, Pfefferkorn M, Mack D, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Mezoff A, Leleiko N, Keljo D, Crandall W (2008) Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 14:949–954

    Article  Google Scholar 

  • Reinshagen M, Schutz E, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, Kruis W, Oellerich M, von Ahsen N (2007) 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. Clin Chem 53:1306–1314

    Article  CAS  Google Scholar 

  • Ridder RM, Kreth HW, Kiss E, Grone HJ, Gordjani N (2005) Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl. Pediatr Nephrol 20:1349–1351

    Article  Google Scholar 

  • Ridder L, de Weersma RK, Dijkstra G, van der Steege G, BenningaMA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC (2007) Genetic susceptibility has a more important role in pediatric-onset Crohn’s disease than in adult-onset Crohn’s disease. Inflamm Bowel Dis 13:1083–1092

    Google Scholar 

  • Ridder L de, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Cucchiara S, Veres G, Ruemmele FM, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Veereman-Wauters G, Braegger CP, Trindade E, Wewer AV, Hauer A, Levine A, Porto IBD Working Group of ESPGHAN (2014) Malignancy and mortality in pediatric patients with inflammatory bowel disease: A multinational study from the porto pediatric IBD group. Inflamm Bowel Dis 20:291–300

    Google Scholar 

  • Ruemmele FM, Lachaux A, Cezard JP, Morali A, Maurage C, Ginies JL, Viola S, Goulet O, Lamireau T, Scaillon M, Breton A, Sarles J, Groupe Francophone d’Hepatologie, Gastroenterologie et Nutrition Pediatrique (2009) Efficacy of infliximab in pediatric Crohn’s disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy. Inflamm Bowel Dis 15:388–394

    Article  Google Scholar 

  • Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martin-de-Capri J, De Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas Lopez VM, Paerregaard A, Russel RK, Serban DE, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D (2014) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis 8:1179–1207

    Article  CAS  Google Scholar 

  • Sabery N, Bass D (2007) Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia. Pediatrics 119:e193–e199

    Article  Google Scholar 

  • Sawczenko A, Sandhu BK (2003) Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 88:995–1000

    Article  CAS  Google Scholar 

  • Schraut WH (2002) The surgical management of Crohn’s disease. Gastroenterol Clin North Am 31:255–263

    Article  CAS  Google Scholar 

  • Shamir R, Phillip M, Levine A (2007) Growth retardation in pediatric Crohn’s disease: pathogenesis and interventions. Inflamm Bowel Dis 13:620–628

    Article  Google Scholar 

  • Sheth SG, LaMont JT (1998) Toxic megacolon. Lancet 351:509–513

    Article  CAS  Google Scholar 

  • Szavay P, Melter M, Hubert O, Pasternak I, Petersen C (1998) Komplikationen bei Kindern mit Colitis ulcerosa nach totaler Kolektomie und J-Pouch-Anlage. (Complications in children with ulcerative colitis after total colectomy and J-pouch). Langenbecks Arch Chir Suppl Kongressbd 115:478–481

    CAS  PubMed  Google Scholar 

  • Treem WR, Cohen J, Davis PM, Justinich CJ, Hyams JS (1995) Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery. Dis Colon Rectum 38:474–479

    Article  CAS  Google Scholar 

  • Turner D, Levine A, Escher JC et al (2012) Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 55:340–361

    Article  CAS  Google Scholar 

  • Uhlig HH, Schwerd T, Koletzko S et al (2014) The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 147:990–1007

    Article  Google Scholar 

  • Walker TR, Land ML, Kartashov A, Saslowsky TM, Lyerly DM, Boone JH, Rufo PA (2007) Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44:414–422

    Article  CAS  Google Scholar 

  • Wong AK, Kerkoutian S, Said J, Rashidi H, Pullarkat ST (2012) Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies. Clin Rheumatol 31:631–636

    Article  Google Scholar 

  • Yokoyama K, Kumaqai H, Mizuta K, Ono S, Imaqawa T, Yamamoto H, Yamaqata T (2016) double-balloon enteroscopy for pediatric patients: evaluation of safety and efficacy inn 257 cases. J Pediatr Gastroenterol Nutr 63:34–40

    Article  Google Scholar 

  • Zhu Q, Li F, Wang J, Shen L, Sheng X (2016) Fecal calprotectin in healthy children aged 1–4 years. Plos One 11(3):e0150725

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Kinder- und Jugendmedizin (KUNO-Kliniken; Klinik St. Hedwig), Universität Regensburg, Regensburg, Deutschland

    Thomas Lang

  2. Kinderchirurgische Klinik, Medizinische Hochschule Hannover, Hannover, Deutschland

    Benno Ure

  3. Klinik und Poliklinik für Kinder- und Jugendmedizin (KUNO-Kliniken), Universität Regensburg, Regensburg, Deutschland

    Michael Melter

Authors
  1. Thomas Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benno Ure
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Melter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Lang .

Editor information

Editors and Affiliations

  1. Kinderchirurgische Klinik und Poliklinik, Klinikum der Universität München Kinderchirurgische Klinik und Poliklinik, München, Bayern, Germany

    Dietrich von Schweinitz

  2. Abt. Kinderchirurgie, Medizinische Hochschule Hannover (MHH) Kinderklinik, Hannover, Germany

    Benno Ure

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Lang, T., Ure, B., Melter, M. (2018). Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen. In: von Schweinitz, D., Ure, B. (eds) Kinderchirurgie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53390-1_57-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53390-1_57-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53390-1

  • Online ISBN: 978-3-662-53390-1

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation